Core-Shell Nanoparticles for Lung Cancer Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current lung cancer treatment strategies, including surgery, radiation therapy, and chemotherapy, have limitations such as high temporary remission rates and severe adverse side effects, particularly for non-small-cell lung cancer patients with un-resectable tumors, due to intrinsic radiation resistance and late-stage diagnosis.
Innovation Solution
Development of multifunctional core-shell nanoparticles comprising a biodegradable polymer core and stimuli-responsive polymer shell, loaded with radiosensitizers and chemotherapeutic agents, which provide controlled and targeted delivery of therapeutic agents, including a burst and sustained release profile, and can be administered via inhalation for enhanced treatment efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional radiation therapy is used to treat non-small-cell lung cancer, then treatment can be administered to patients with un-resectable tumors, but the treatment fails due to intrinsic radiation resistance and DNA repair ability
Solution Approach 1:
The patent introduces a nanoparticle carrier as an intermediary that delivers radiosensitizing agents to tumor cells. These agents act as mediators between radiation therapy and DNA repair mechanisms, enhancing radiation-induced DNA damage while inhibiting repair pathways, thereby overcoming intrinsic radiation resistance
Solution Approach 2:
The invention uses composite nanoparticle structures combining multiple functional components: radiosensitizing agents, chemotherapeutic agents, and targeting ligands. This composite approach allows simultaneous delivery of multiple therapeutic mechanisms that work synergistically to overcome radiation resistance and improve treatment reliability
2Reliability
If conventional chemotherapy is used to treat lung cancer, then some tumor response can be achieved, but severe adverse side effects occur due to systemic delivery
Solution Approach 1:
The nanoparticle system implements local quality by equipping particles with tumor-specific targeting ligands on their surface. This allows chemotherapeutic agents to be selectively delivered to tumor cells expressing specific receptors, concentrating the therapeutic effect locally at the tumor site while minimizing exposure and side effects in healthy tissues
Solution Approach 2:
The invention segments the chemotherapy delivery system into targeted nanoparticle carriers that can navigate to tumor sites and release drugs locally. This segmentation separates the therapeutic action from systemic circulation, maintaining treatment response while reducing adverse side effects through localized drug release
3Reliability
If single-function treatment approaches are used, then treatment simplicity is maintained, but treatment efficacy is limited due to inability to overcome radiation resistance and address multifactorial cancer biology
Solution Approach 1:
The nanoparticle system embodies multi-functionality by integrating multiple therapeutic modalities into a single platform: radiosensitization, chemotherapy, and targeted delivery. This universal approach allows simultaneous execution of multiple treatment functions that address different aspects of cancer biology and radiation resistance, improving overall treatment efficacy
Solution Approach 2:
The invention merges distinct therapeutic approaches (radiation sensitization and chemotherapy) into a unified nanoparticle delivery system. By combining these modalities in a single administered formulation, the treatment achieves synergistic effects while simplifying the administration process despite the complexity of the multifunctional therapy
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoparticles offer a targeted and controlled therapy with enhanced radiation sensitivity and chemotherapy efficacy, reducing toxicity and side effects while improving treatment outcomes for lung cancer patients by delivering therapeutic agents directly to the tumor site with precise release profiles.
Implementation Method 1
the shell component is temperature-responsive and/or pH-responsive or is formed from a temperature-responsive and/or pH-responsive polymer
Implementation Method 2
the shell component is temperature-responsive and/or pH-responsive or is formed from a temperature-responsive and/or pH-responsive polymer
Implementation Method 3
one or more radiosensitizers are disposed in or dispersed throughout the core component... one or more chemotherapeutic agents are disposed in or dispersed throughout the shell component
Data Source
AI summary
In one aspect, compositions comprising a population of core-shell nanoparticles are described herein. In some cases, the population of core-shell nanoparticles comprises a core component and a shell component encapsulating or surrounding the core component. Additionally, one or more radiosensitizers are disposed in or dispersed throughout the core component, or an interior region of the core component. Similarly, one or more chemotherapeutic agents are disposed in or dispersed throughout the shell component, or an interior region of the shell component. Moreover, in some cases, the core component is formed from one or more biodegradable polymers. Further, in some instances, the shell component is formed from one or more stimuli responsive polymers, such as a temperature-responsive polymer and/or pH-responsive polymer.